News & Events

February 5, 2025

Podcast | ‘Show me the molecule’ – On synthetic biology and cutting through AI hype

January 10, 2025

Press release | LabGenius Appoints Dr. Hannah Seitz as Chief Business Officer

October 22, 2024

Award | LabGenius recognised as one of Bloomberg’s start-ups to watch

July 19, 2024

Podcast | Cutting through the AI hype in drug discovery

July 7, 2024

Publication | Best practices for machine learning in antibody discovery and development

June 6, 2024

Podcast | Antibody discovery with LabGenius’ James Field and Balderton’s James Wise

May 21, 2024

Blog | A personal perspective on LabGenius’ £35M raise from CEO, James Field

May 21, 2024

Article | UK biotech raises £35M to develop solid tumour drugs based on machine learning

James Field (LabGenius) and Oliver Hardick (M Ventures) standing in a lab wearing white lab coats and safety glasses
May 21, 2024

Press release | LabGenius raises £35 million led by M Ventures to further develop its ML-driven antibody discovery platform and progress a pipeline of assets towards the clinic

May 11, 2024

Feature | LabGenius featured in BBC Click episode, ‘Combating Cancer’

April 30, 2024

Interview | James Field describes how LabGenius is using machine intelligence to design the next generation of multispecific antibodies

April 5, 2024

Publication | Applications and challenges in designing VHH-based bispecific antibodies: leveraging machine learning solutions